Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Myron David Kor who wrote (1472)	1/2/1998 12:16:00 AM
From: Craig Markell	Read Replies (1) \| Respond to of 7041

From Motely Fool on AOL (Subject: White Paper) (Contact Zonagen for copy) ---------------------------------------------- Subject: White paper Date: 12/31/97 3:46 PM Eastern Standard Time Just finished reading the paper. It read well, and was basically just what Joe said it would be in the last conference call. I was a good cronological explanation of the development of Vasomax. It does go into some detail of all the patent issues, trial results, and marketing strategies, but really does not expand on most of the data and information we have already seen. This I'm sure is at the request/insistance of SGP. Obviously, for the purpose of not giving the competition to much information. For all those posters who have not been involved with Zonagen a long time, this is a must read paper. It will bring you up to date on Vasomax and refute much of the BS being spouted by the short attackers here and SI. Many of those who attack Zonagen make reference to this and that, but do not post what these references say or mean. They just make comments like "Well, what about ZON-301?", or make reference to trial patients having had heart attacks, with no substanciation. Well, facts are there were not heart attacks. What the short attackers would have you beleive is that, I beleive in the Zon-301 study, where they were testing a 80mg dose, (which is twice the recomended dose), one patient experienced an increase in heart rate and a decrease in BP of more that 30%, and one patient experienced chest pain. A far cry from a heart attack. These were the only significant adverse effects in hundreds of patients. They were given the 80mg dose to test the effects of someone voluntarily doubling the recomended dosage. No other serious adverse effects were reported in the trial. Everyone investing in Zonagen should read this paper to help give you a good base of information on the development of Vasomax. Do your own DD from then on, and don't get caught listned to unsubstaciated attacks and taking them for fact..

To: Myron David Kor who wrote (1472)	1/2/1998 5:35:00 PM
From: Dauntless	Read Replies (1) \| Respond to of 7041

Myron & Thread What do you think the odds are that the Purveyor of Poop will be at the conference in Feb? He really SHOULD attend, you know, so he can save dozens, hell maybe hundreds, of old ladies & children from losing all their money. I know one woman, single mom with two kids approaching college age, who put $20,000 that the kid's grandfather had left them into Zonagen stock at Christmas time last year. I think her buy price was around $10/share. She sold half at $31 & is still holding the rest - the $20K is now $50K in one year. Boy, can you imagine how ticked off she is at the crooks at Zonagen that are responsible for ruining her life. Think of how many people could be saved by the P.o.P. if he would only stand up at the meeting and warn everyone. I, for one, would love to shake his hand & thank him for his SELFLESS good works. Maybe we could also settle our bet?